Brief: IDL Diagnostics Q2 EBITDA Loss Narrows To SEK 148,000
20/08/2026 07:10
BRIEF-IDL Diagnostics Q2 EBITDA Loss Narrows To SEK 148,000 Aug 20 (Reuters) - IDL Diagnostics AB (publ) IDLDX.ST:
Q2 NET SALES AMOUNT TO SEK 14,556 THOUSAND
Q2 EBITDA AT SEK –148 THOUSAND
Source text: ID:nMFN8TLz6k
Further company coverage: IDLDX.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))